Loading…
Oculis Holding AG is projected to rise to $14.75 by 2027, a +30% move from its current price of $11.31. OCS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $11.02 | $11.32 | $11.63 | +0.09% |
| Aug 3 | $10.90 | $11.33 | $11.77 | +0.17% |
| Aug 4 | $10.82 | $11.34 | $11.89 | +0.26% |
| Aug 5 | $10.75 | $11.35 | $11.98 | +0.34% |
| Aug 6 | $10.69 | $11.36 | $12.07 | +0.43% |
| Aug 7 | $10.63 | $11.37 | $12.15 | +0.51% |
| Aug 8 | $10.59 | $11.38 | $12.23 | +0.60% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $10.59 | $11.38 | $12.23 | +0.60% |
| Week 2 | $10.34 | $11.45 | $12.68 | +1.21% |
| Week 3 | $10.16 | $11.52 | $13.05 | +1.81% |
| Week 4 | $10.03 | $11.58 | $13.38 | +2.43% |
| Week 5 | $9.92 | $11.65 | $13.69 | +3.04% |
| Week 6 | $9.83 | $11.72 | $13.99 | +3.66% |
| Week 7 | $9.75 | $11.79 | $14.27 | +4.28% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
OCS is the stock ticker for Oculis Holding AG, a healthcare company that develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally.
The company is based in Zug, Switzerland and was founded in 2017. It changed its name from Oculis SA to Oculis Holding AG in March 2023.
Its lead programs include OCS-01, a topical dexamethasone optireach formulation, in Phase 3 for diabetic macular edema; OCS-02, a topical biologic candidate, in Phase 2b for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration, diabetic retinopathy, and acute optic neuritis.
OCS is the stock for a clinical-stage biopharmaceutical company in the Healthcare sector, currently priced at $11.13 per share with a market capitalization of $672.12M and a market rank of 2642.
The current price sits within a framework of a defined chart; the forecast shows a path of potential upside over time, with a neutral stance in 2026 and increasingly bullish momentum in following years. The average price projection rises from $11.13 in 2026 to $14.73 in 2027, and to $18.13 by 2030, continuing to $48.21 in 2040 and $82.64 in 2050, with a corresponding rise in expected ROI.
Key forecast milestones include 2026 with an avg of $11.13 and ROI of 0 (neutral), followed by progressively higher averages and stronger bullish sentiment through 2050, where the avg reaches $82.64 and the max hits $159.98 with a ROI of 642.5.
A major floor 22.1% below — a decisive break under it would weaken the trend.
The nearest floor, 4.2% below — buyers have tended to step in here.
The nearest ceiling, 24.8% above — a clean break opens room to run.
A major ceiling 188.7% above — clearing it would confirm fresh momentum.
Key OCS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OCS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.09 | Buy | $11.21 | Buy |
| MA 10 | $11.31 | Sell | $11.45 | Sell |
| MA 20 | $12.28 | Sell | $12.05 | Sell |
| MA 50 | $14.45 | Sell | $14.94 | Sell |
| MA 100 | $20.93 | Sell | $18.30 | Sell |
| MA 200 | $22.01 | Sell | $20.08 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 35.24 | Neutral |
| Stoch RSI (14) | 59.72 | Neutral |
| CCI (20) | -66.25 | Neutral |
| Williams %R (14) | -79.39 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | -13.80 | Sell |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 20.61 | Neutral |
| TRIX (15) | -1.04 | Sell |
| Awesome (5,34) | -1.13 | Sell |
| Ultimate (7,14,28) | 39.63 | Neutral |
| Momentum (10) | -0.88 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 11.01 | Buy |
| ADX (14) | 32.67 | Sell |
| ATR (14) | 0.34 | Info |
The 30-day technical picture is neutral, with RSI14 at 30.
The moving averages show SMA50 at $16.68 and SMA200 at $22.28, indicating near-term resistance above the current price. Support is listed at $10.97 and resistance at $14.12, framing the nearby level for price action.
The 30-day range spans from $9.09 to $13.63, reflecting a relatively tight trading window around the current level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.71 | $11.31 | $16.20 | 0% | Neutral | |
| $11.76 | $14.75 | $19.55 | +30% | Bullish | |
| $13.78 | $17.77 | $24.45 | +57% | Bullish | |
| $14.48 | $19.11 | $27.07 | +69% | Bullish | |
| $13.77 | $18.55 | $26.94 | +64% | Bullish | |
| $15.00 | $20.59 | $30.54 | +82% | Bullish | |
| $16.34 | $22.82 | $34.50 | +102% | Bullish | |
| $19.46 | $27.62 | $42.48 | +144% | Bullish | |
| $21.97 | $31.67 | $49.50 | +180% | Bullish | |
| $21.02 | $30.75 | $48.78 | +172% | Bullish | |
| $30.98 | $48.45 | $81.76 | +328% | Bullish | |
| $48.95 | $85.90 | $158.60 | +660% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $10.71 | $11.31 | $14.27 | +0.00% |
| September 2026 | $10.11 | $11.97 | $14.56 | +5.81% |
| October 2026 | $10.27 | $12.23 | $15.04 | +2.19% |
| November 2026 | $10.71 | $12.83 | $15.91 | +4.90% |
| December 2026 | $10.77 | $12.96 | $16.20 | +1.05% |
Click any year to see its month-by-month OCS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The OCS price prediction for 2026 points to an average of $11.31 (low $10.71, high $16.20) — a potential gain of 0% on today's $11.31. Price action looks broadly range-bound.
In 2027, OCS is projected to trade between $11.76 and $19.55, averaging $14.75 — a potential gain of +30% from today's $11.31. That is up +30% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Oculis Holding AG's 2028 outlook centres on $17.77, within a $13.78 to $24.45 range. That is up +21% on the projected 2027 average. That marks a +57% change versus current levels. Momentum favours further upside here.
By 2029, OCS could reach as high as $27.07, with a base case around $19.11 and support toward $14.48 — roughly +69% from $11.31. Buyers look set to stay in control over this stretch.
Expect OCS to range from $13.77 to $26.94 through 2030. The $18.55 average target implies a +64% move from current prices. That is -3% versus the projected 2029 average. Momentum favours further upside here.
The OCS price prediction for 2031 points to an average of $20.59 (low $15.00, high $30.54) — a potential gain of +82% on today's $11.31. Buyers look set to stay in control over this stretch.
In 2032, OCS is projected to trade between $16.34 and $34.50, averaging $22.82 — a potential gain of +102% from today's $11.31. That is up +11% on the projected 2031 average. Momentum favours further upside here.
Oculis Holding AG's 2033 outlook centres on $27.62, within a $19.46 to $42.48 range. That is up +21% on the projected 2032 average. That marks a +144% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, OCS could reach as high as $49.50, with a base case around $31.67 and support toward $21.97 — roughly +180% from $11.31. Momentum favours further upside here.
Expect OCS to range from $21.02 to $48.78 through 2035. The $30.75 average target implies a +172% move from current prices. That is -3% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
The OCS price prediction for 2040 points to an average of $48.45 (low $30.98, high $81.76) — a potential gain of +328% on today's $11.31. Momentum favours further upside here.
In 2050, OCS is projected to trade between $48.95 and $158.60, averaging $85.90 — a potential gain of +660% from today's $11.31. That is up +77% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in OCS today (≈ 88.41733 OCS) could be worth
$7,595.45
+$6,595.45 (+660%) by 2050 · US Dollar
Based on the average projected OCS price of $85.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OCSwould be worth at today's price.
$1,000 invested in OCS on Jul 31, 2025 (≈ 56.689344 OCS) would be worth
$641.16
-$358.84 (-35.9%) today · 0.64× · US Dollar
Based on a OCS entry price of $17.64 vs. today's $11.31.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.13 | $1,016.17 | +1.6% |
| 1 month ago | $13.53 | $835.92 | -16.4% |
| 3 months ago | $27.48 | $411.57 | -58.8% |
| 6 months ago | $29.03 | $389.6 | -61.0% |
| 1 year ago | $17.64 | $641.16 | -35.9% |
| All time (5.0y) ago | $9.66 | $1,170.81 | +17.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OCS forecast.
Our base-case forecast reaches $23.00 around 2033.
Implied market cap at $23.00: $1.39B
Over the multi-year horizon, the forecast shifts to a bullish stance from 2027 onward. The 2027 avg price is $14.73, rising from the 2026 level and accompanied by a 32.4% ROI, signaling upside potential as the price trajectory broadens.
Forecasts for 2028 and 2029 strengthen further, with avg prices of $17.95 and $18.97 and ROI of 61.3% and 70.4%, respectively, underscoring sustained upside momentum.
By 2030 the avg price is projected at $18.13 with a 62.9% ROI, and sentiment remains bullish through the early 2030s. The long-run path accelerates toward 2040 (avg $48.21, ROI 333.2) and reaches a peak in 2050 (avg $82.64, max $159.98, ROI 642.5), with the implied sentiment staying bullish.
The forecast implies significant upside as prices rise across years, but these are estimates and not guarantees. The 2026 view is neutral with a 0 ROI, highlighting that near-term outcomes can differ from longer-term projections.
Tap a question to reveal the answer.
In 2030 the forecast lists a min of $13.15, an avg of $18.13, and a max of $27.03, with an ROI of 62.9% and a bullish sentiment.
The forecast shows bullish sentiment from 2027 onward, with rising averages and ROI: 2027 avg $14.73 (ROI 32.4%), 2028 avg $17.95 (ROI 61.3%), and 2050 avg $82.64 with ROI 642.5%, though 2026 is neutral with ROI 0.
The 2035 forecast lists a max of $49.14, which is below $50, so reaching $50 by 2035 is not indicated by the forecast.
The current price is $11.13 and the market capitalization is $672.12M.
The RSI14 is 30 with neutral sentiment. SMA50 is $16.68 and SMA200 is $22.28, with a support level at $10.97 and a resistance level at $14.12. The 30-day range is $9.09 to $13.63.
Oculis Holding AG Community Discussion
0Share your Oculis Holding AG price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.